PUBLICATION

Polyphenols from Euphorbia pekinensis Inhibit AGEs Formation In Vitro and Vessel Dilation in Larval Zebrafish In Vivo

Authors
Lee, I.S., Jung, S.H., Kim, J.S.
ID
ZDB-PUB-171123-8
Date
2017
Source
Planta Medica   84(3): 176-181 (Journal)
Registered Authors
Jung, Seung-Hyun
Keywords
none
MeSH Terms
  • Animals
  • Chemical Fractionation
  • Ellagic Acid/analogs & derivatives
  • Euphorbia/chemistry*
  • Glycation End Products, Advanced/drug effects*
  • Hypoglycemic Agents/chemistry
  • Hypoglycemic Agents/isolation & purification
  • Hypoglycemic Agents/pharmacology*
  • Larva/drug effects
  • Molecular Structure
  • Polyphenols/chemistry
  • Polyphenols/isolation & purification
  • Polyphenols/pharmacology*
  • Retinal Vessels/drug effects
  • Vasodilation/drug effects
  • Zebrafish
PubMed
29165729 Full text @ Planta Med.
Abstract
To identify active compounds in the roots of Euphorbia pekinensis for treatment of diabetic complications, an active column fraction from a 70% EtOH extract of E. pekinensis root was purified by preparative reversed-phase high-performance liquid chromatography, leading to the isolation of a new ellagic acid derivative, 3,3'-di-O-methylellagic acid 4-O-(6"-O-galloyl)-β-D-galactopyranoside (1: ), along with three known compounds, geraniin (2: ), 3,3'-di-O-methylellagic acid 4-O-β-D-xylopyranoside (3: ), and ellagic acid 3,3'-dimethyl ether (4: ). The structure of the new compound was established by extensive spectroscopic studies and chemical evidence. The inhibitory effects of isolated compounds 1: -4: on advanced glycation end-products (AGEs) formation were examined. All compounds exhibited considerable inhibition of AGEs formation and IC50 values of 0.41 - 12.33 µM, compared with those of the positive controls aminoguanidine (IC50 = 1122.34 µM) and quercetin (IC50 = 27.80 µM). In addition, the effects of 2: and 4: on the dilation of hyaloid-retinal vessels induced by high glucose (HG) in larval zebrafish were investigated; both compounds significantly reduced the HG-induced dilation of hyaloid-retinal vessels relative to the HG-treated control group.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping